抗核抗体（ANA）検査の世界市場予測（～2021年）：試薬＆検定キット、装置、ソフトウェア、サービス...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Antinuclear Antibody Test Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Incidence of Autoimmune Diseases
5.3.1.2 Increasing Population and Growth in Healthcare Expenditure
5.3.1.3 Growth in the Number of Individuals Covered Under Medical Insurance
5.3.2 Restraints
5.3.2.1 Stringent Regulations for the Approval of Medical Devices
5.3.2.2 Implementation of Excise Duty on Medical Devices in the U.S.
5.3.2.3 Requirement of Significant Capital to Purchase High-Cost Equipment
5.3.3 Opportunities
5.3.3.1 Laboratory Automation
5.3.3.2 Emerging Markets in Asia Present High-Growth Opportunities
5.3.4 Trend
5.3.4.1 Reagent Rental Agreements

6 Antinuclear Antibody Test Market, By Product (Page No. – 47)
6.1 Introduction
6.2 Reagents & Assay Kits
6.3 Systems
6.4 Software & Services

7 Antinuclear Antibody Test Market, By Technique (Page No. – 53)
7.1 Introduction
7.2 Elisa
7.3 Immunofluorescence Assay
7.4 Multiplex Assay

8 Antinuclear Antibody Test Market, By Disease (Page No. – 60)
8.1 Introduction
8.2 Rheumatoid Arthritis
8.3 Systemic Lupus Erythematosus
8.4 Sjögren’s Syndrome
8.5 Scleroderma
8.6 Other Diseases

9 Antinuclear Antibody Test Market, By End User (Page No. – 69)
9.1 Introduction
9.2 Hospitals
9.2.1 Small Hospitals
9.2.2 Mid-Sized Hospitals
9.2.3 Large Hospitals
9.3 Clinical Laboratories
9.4 Physician Office Laboratories
9.5 Other End Users

10 Geographic Analysis (Page No. – 80)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of the Asia (RoA)
10.5 Rest of the World

11 Competitive Landscape (Page No. – 132)
11.1 Introduction
11.2 Strategic Overview
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Acquisitions
11.4.2 Agreements
11.4.3 New Product Launches
11.4.4 Expansions
11.4.5 Other Developments

12 Company Profiles (Page No. – 138)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.3 Alere Inc.
12.4 Bio-Rad Laboratories, Inc.
12.5 Trinity Biotech PLC
12.6 Erba Diagnostics, Inc.
12.7 Antibodies Inc.
12.8 Euroimmun AG
12.9 Immuno Concepts
12.10 Inova Diagnostics
12.11 Zeus Scientific, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 159)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports